Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,645.20
(
0.63%
)
Dow Jones
45,166.64
(
0.00%
)
Brent Oil
107.60
(
-0.61%
)
Bitcoin
67,581.42
(
2.46%
)
News Focus
News Focus

Replies to post #2091 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #2091 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

11/19/21 11:41 AM

#2093 RE: willyw #2091

But JNJ-3939 is an injected drug. ENTA's distinction has been pursuing an all-oral functional cure. If ENTA drops the all-oral requirement, there are many competitors in the HBV arena.